Narwhal Capital Management Abbott Laboratories Transaction History
Narwhal Capital Management
- $1.09 Billion
- Q4 2024
A detailed history of Narwhal Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Narwhal Capital Management holds 51,473 shares of ABT stock, worth $6.52 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
51,473
Previous 22,338
130.43%
Holding current value
$6.52 Million
Previous $2.55 Million
128.67%
% of portfolio
0.53%
Previous 0.23%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,376Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$21.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.78 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.61 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.85 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $222B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...